中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2010年
1期
38-39
,共2页
石李金%许敏%高琴%黄仑峰%陶莹%严谨%詹鑫亮
石李金%許敏%高琴%黃崙峰%陶瑩%嚴謹%詹鑫亮
석리금%허민%고금%황륜봉%도형%엄근%첨흠량
尿激酶%胸膜炎%结核
尿激酶%胸膜炎%結覈
뇨격매%흉막염%결핵
Urokinase%Pleural effusion%Tuberculous pleurisy
目的 观察和评价胸腔内注入尿激酶治疗结核性胸膜炎的疗效.方法 将确诊的结核性膜炎患者40例,随机均分为尿激酶治疗组和对照组,在常规应用抗结核药物和胸穿抽液的基础上,尿激酶治疗组于每次抽液后用注入生理盐水20 ml稀释尿激酶10万u,对照组在胸穿抽液后注入生理盐水20 ml,两组抗结核化疗方案相同.结果 治疗组在抽液量、胸膜厚度、胸膜粘连度与对照组有显著性差异(P＜0.05).结论 胸腔内注入尿激酶治疗结核性胸膜炎可以增加抽胸液量,减轻胸膜肥厚、粘连,改善肺功能.
目的 觀察和評價胸腔內註入尿激酶治療結覈性胸膜炎的療效.方法 將確診的結覈性膜炎患者40例,隨機均分為尿激酶治療組和對照組,在常規應用抗結覈藥物和胸穿抽液的基礎上,尿激酶治療組于每次抽液後用註入生理鹽水20 ml稀釋尿激酶10萬u,對照組在胸穿抽液後註入生理鹽水20 ml,兩組抗結覈化療方案相同.結果 治療組在抽液量、胸膜厚度、胸膜粘連度與對照組有顯著性差異(P＜0.05).結論 胸腔內註入尿激酶治療結覈性胸膜炎可以增加抽胸液量,減輕胸膜肥厚、粘連,改善肺功能.
목적 관찰화평개흉강내주입뇨격매치료결핵성흉막염적료효.방법 장학진적결핵성막염환자40례,수궤균분위뇨격매치료조화대조조,재상규응용항결핵약물화흉천추액적기출상,뇨격매치료조우매차추액후용주입생리염수20 ml희석뇨격매10만u,대조조재흉천추액후주입생리염수20 ml,량조항결핵화료방안상동.결과 치료조재추액량、흉막후도、흉막점련도여대조조유현저성차이(P＜0.05).결론 흉강내주입뇨격매치료결핵성흉막염가이증가추흉액량,감경흉막비후、점련,개선폐공능.
Objective To investigate the effects of intrapleural injection of urokinase in treatment of tuberculous pleurisy. Methods The 40 cases with tuberculous pleural effusion were randomly divided into treatment group and control group. The cases in treatment group were treated with 100 000 IU urokinase( diluted by 20 ml normal saline) after draining effusion and those in the control group were only given normal saline after draining of effusion. Results The effects in treatment group was significantly superior to those of the control group ( P ＜0.05). Conclusion Intrapleural urokinase is effective for treatment of patients with tuberculous pleurisy.
